Literature DB >> 20862774

Peptide transporter 1 is responsible for intestinal uptake of the dipeptide glycylsarcosine: studies in everted jejunal rings from wild-type and Pept1 null mice.

Katherine Ma1, Yongjun Hu, David E Smith.   

Abstract

The purpose of this study was to determine the relative importance of peptide transporter 1 (PEPT1) in the uptake of peptides/mimetics from mouse small intestine, using glycylsarcosine (GlySar). After isolating jejunal tissue from wild-type and Pept1 null mice, 2 cm intestinal segments were everted and mounted on glass rods for tissue uptake studies. [(14)C]GlySar (4 μM) was studied as a function of time, temperature, sodium and pH, concentration, and potential inhibitors. Compared with wild-type animals, Pept1 null mice exhibited a 78% reduction in GlySar uptake at pH 6.0 at 37°C. GlySar uptake showed pH dependence, with peak values between pH 6.0 and 6.5 in wild-type animals, whereas no such tendency was observed in Pept1 null mice. GlySar exhibited Michaelis-Menten uptake kinetics and a minor nonsaturable component in wild-type animals. In contrast, GlySar uptake occurred only by a nonsaturable process in Pept1 null mice. GlySar uptake was significantly inhibited by dipeptides, aminocephalosporins, angiotensin-converting enzyme inhibitors, and the antiviral prodrug valacyclovir; these inhibitors had little, if any, effect on the uptake of GlySar in Pept1 null mice. The findings demonstrate that PEPT1 plays a critical role in the uptake of GlySar in jejunum and suggest that PEPT1 is the major transporter responsible for the intestinal absorption of small peptides.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20862774      PMCID: PMC3010518          DOI: 10.1002/jps.22277

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  26 in total

Review 1.  An update on renal peptide transporters.

Authors:  Hannelore Daniel; Isabel Rubio-Aliaga
Journal:  Am J Physiol Renal Physiol       Date:  2003-05

Review 2.  Mammalian peptide transporters as targets for drug delivery.

Authors:  Isabel Rubio-Aliaga; Hannelore Daniel
Journal:  Trends Pharmacol Sci       Date:  2002-09       Impact factor: 14.819

3.  Functional evidence for presence of PEPT2 in rat choroid plexus: studies with glycylsarcosine.

Authors:  N S Teuscher; A Novotny; R F Keep; D E Smith
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

4.  Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues.

Authors:  D Herrera-Ruiz; Q Wang; O S Gudmundsson; T J Cook; R L Smith; T N Faria; G T Knipp
Journal:  AAPS PharmSci       Date:  2001

5.  Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1.

Authors:  D A Groneberg; F Döring; P R Eynott; A Fischer; H Daniel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

Review 6.  Current perspectives on established and putative mammalian oligopeptide transporters.

Authors:  Dea Herrera-Ruiz; Gregory T Knipp
Journal:  J Pharm Sci       Date:  2003-04       Impact factor: 3.534

7.  cDNA structure, genomic organization, and promoter analysis of the mouse intestinal peptide transporter PEPT1.

Authors:  Y J Fei; M Sugawara; J C Liu; H W Li; V Ganapathy; M E Ganapathy; F H Leibach
Journal:  Biochim Biophys Acta       Date:  2000-06-21

8.  Investigation of the role of oligopeptide transporter PEPT1 and sodium/glucose cotransporter SGLT1 in intestinal absorption of their substrates using small GTP-binding protein Rab8-null mice.

Authors:  Yukio Kato; Tomoko Sugiura; Yasuhito Nakadera; Mikihiro Sugiura; Yoshiyuki Kubo; Takashi Sato; Akihiro Harada; Akira Tsuji
Journal:  Drug Metab Dispos       Date:  2008-12-12       Impact factor: 3.922

9.  Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine.

Authors:  Yongun Hu; David E Smith; Ke Ma; Dilara Jappar; Winston Thomas; Kathleen M Hillgren
Journal:  Mol Pharm       Date:  2008 Nov-Dec       Impact factor: 4.939

10.  Diurnal rhythm of H+-peptide cotransporter in rat small intestine.

Authors:  Xiaoyue Pan; Tomohiro Terada; Megumi Irie; Hideyuki Saito; Ken-Ichi Inui
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-07       Impact factor: 4.052

View more
  9 in total

1.  Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Dilara Jappar; Yongjun Hu; David E Smith
Journal:  Drug Metab Dispos       Date:  2011-08-31       Impact factor: 3.922

2.  Mechanisms of gemcitabine oral absorption as determined by in situ intestinal perfusions in mice.

Authors:  Brian R Thompson; Yongjun Hu; David E Smith
Journal:  Biochem Pharmacol       Date:  2019-06-14       Impact factor: 5.858

3.  Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Ke Ma; Yongjun Hu; David E Smith
Journal:  Pharm Res       Date:  2011-09-09       Impact factor: 4.200

4.  The effects of dietary sulfur amino acids on growth performance, intestinal morphology, enzyme activity, and nutrient transporters in weaning piglets.

Authors:  Enyan Zong; Pengfei Huang; Wei Zhang; Jianzhong Li; Yali Li; Xueqing Ding; Xia Xiong; Yulong Yin; Huansheng Yang
Journal:  J Anim Sci       Date:  2018-04-03       Impact factor: 3.159

Review 5.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

6.  Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice.

Authors:  Bei Yang; David E Smith
Journal:  Drug Metab Dispos       Date:  2012-12-21       Impact factor: 3.922

7.  Functional intercalated nanocomposites with chitosan-glutathione-glycylsarcosine and layered double hydroxides for topical ocular drug delivery.

Authors:  Tingting Xu; Xiaoyue Xu; Yan Gu; Lei Fang; Feng Cao
Journal:  Int J Nanomedicine       Date:  2018-02-13

8.  Brain-transportable dipeptides across the blood-brain barrier in mice.

Authors:  Mitsuru Tanaka; Shinya Dohgu; Genki Komabayashi; Hayato Kiyohara; Fuyuko Takata; Yasufumi Kataoka; Takashi Nirasawa; Motohiro Maebuchi; Toshiro Matsui
Journal:  Sci Rep       Date:  2019-04-08       Impact factor: 4.379

9.  The Dipeptide Pro-Gly Promotes IGF-1 Expression and Secretion in HepG2 and Female Mice via PepT1-JAK2/STAT5 Pathway.

Authors:  Mengyuan Zhang; Jingren Xu; Tao Wang; Xiaojuan Wan; Fenglin Zhang; Lina Wang; Xiaotong Zhu; Ping Gao; Gang Shu; Qingyan Jiang; Songbo Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-26       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.